MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma

American Journal of Neuroradiology

Volumn 34, Issue 7, 2013, Pages 1450-1455

  Sedlacik, J ^a   Winchell, A ^a   Kocak, M ^a,b   Loeffler, R B ^a   Broniscer, A ^a   Hillenbrand, C M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANDETANIB;

ADOLESCENT; ARTICLE; CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL; PONTINE GLIOMA; PRESCHOOL CHILD; SCHOOL CHILD; SEDATION; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BLOOD VOLUME; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; ECHO-PLANAR IMAGING; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; NEOADJUVANT THERAPY; NEUROIMAGING; PIPERIDINES; PROSPECTIVE STUDIES; QUINAZOLINES; RADIOTHERAPY, CONFORMAL; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84880832750     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3421     Document Type: Article

References (28)

1. Broniscer A, Gajjar A. Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 2004;9:197-206.
2. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 2006;7:241-48.
3. Broniscer A, Baker JN, Tagen M, et al. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 2010;28:4762-68.
4. Hargrave D, Chuang N, Bouffet E. ConventionalMRIcannot predict survival in childhood diffuse intrinsic pontine glioma. J Neurooncol 2008;86:313-19.
5. Sedlacik J, Lobel U, Kocak M, et al. Attenuation of cerebral venous contrast in susceptibility-weighted imaging of spontaneously breathing pediatric patients sedated with propofol. AJNR Am J Neuroradiol 2010;31:901-06.
6. Mugler III JP, Wald LL, Brookeman JR. T2-weighted 3D spin echo train imaging of the brain at 3 Tesla: Reduced power deposition using low flip-angle refocusing RF pulses. In: Proceedings of the International Society for Magnetic Resonance Imaging; April 21-27, 2001; Glasgow, United Kingdom. Abstract 438.
7. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectationmaximization algorithm. IEEE Trans Med Imaging 2001;20:45-57.
8. Mugler JP 3rd, Brookeman JR. Three-dimensional magnetizationprepared rapid gradient-echo imaging (3DMPRAGE). Magn Reson Med 1990;15:152-57.
9. Luh WM, Wong EC, Bandettini PA, et al. QUIPS S II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246-54.
10. Thesen S, Heid O, Mueller E, et al. Prospective acquisition correction for head motion with image-based tracking for real-time fMRI. Magn Reson Med 2000;44:457-65.
11. Lüdemann L, Warmuth C, Plotkin M, et al. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol 2009;70: 465-74.
12. Wang J, Alsop DC, Li L, et al. Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 2002;48:242-54.
13. Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726-36.
14. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-25.
15. Jenkinson M, Bannister P, Brady M, et al. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825-41.
16. Macdonald DR, Cascino TL, Schold SC Jr, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80.
17. Poussaint TY, Kocak M, Vajapeyam S, et al. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol 2011; 13:417-27.
18. Gutmann R, Leunig M, Feyh J, et al. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 1992;52:1993-95.
19. Znati CA, Rosenstein M, Boucher Y, et al. Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft. Cancer Res 1996;56:964-68.
20. Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 2007;67:2729-35.
21. Sorensen AG, Emblem KE, Polaskova P, et al. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res 2012;72:402-07.
22. Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490-98.
23. Hipp SJ, Steffen-Smith E, Hammoud D, et al. Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol 2011;13:904-09.
24. Löbel U, Sedlacik J, Reddick WE, et al. Quantitative diffusionweighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNRAmJ Neuroradiol 2011;32:315-22.
25. Young R, Babb J, Law M, et al. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 2007;26:1053-63.
26. Günther M, Oshio K, Feinberg DA. Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med 2005;54:491-98.
27. Song R, Loeffler RB, Hillenbrand CM. QUIPS S II with windowsliding saturation sequence (Q2WISE). Magn Reson Med 2012;67: 1127-32.
28. Willats L, Christensen S, Ma HK, et al. Validating a local Arterial Input Function method for improved perfusion quantification in stroke. J Cereb Blood Flow Metab 2011;31:2189-98.